Total Knee Arthroplasty clinical trials

Explore recruiting total knee arthroplasty clinical trials.

Recruiting total knee arthroplasty studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Total Knee Arthroplasty trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Randomized, Open-Label, Blinded Endpoint Evaluation, Active-Controlled Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing Elective Primary Unilateral Total Knee Arthroplasty.

Latvia, Bulgaria, Hungary, Czechia, Poland, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Multicenter, Randomized, Open-label, Active-Control Study of REGN7508, a Factor XI Monoclonal Antibody, for the Prevention of Venous Thromboembolism in Participants Undergoing an Elective, Unilateral, Total Knee Arthroplasty (ROXI-VTE II)

Bulgaria, Poland, Hungary, Latvia, Lithuania

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase III Randomized, Double-Blind Clinical Trial to Determine the Role of Magnesium Sulfate in Adductor Canal Block in Total Knee Arthroplasty

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Effects of 10 vs. 20 mL Local Anesthetic for Popliteal Plexus Block on Opioid Consumption, Pain, and Patient-Reported Outcomes after Total Knee Arthroplasty - a randomized, controlled, blinded study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX).

Bulgaria, Lithuania, Poland, Hungary, Latvia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Greece, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Total Knee Arthroplasty trials by city

Total Knee Arthroplasty in Toronto Total Knee Arthroplasty in Vancouver Total Knee Arthroplasty in Montreal Total Knee Arthroplasty in Calgary Total Knee Arthroplasty in Edmonton Total Knee Arthroplasty in Ottawa Total Knee Arthroplasty in Winnipeg Total Knee Arthroplasty in Quebec City Total Knee Arthroplasty in Hamilton Total Knee Arthroplasty in Kitchener Total Knee Arthroplasty in London Total Knee Arthroplasty in Halifax Total Knee Arthroplasty in New York Total Knee Arthroplasty in Los Angeles Total Knee Arthroplasty in Chicago Total Knee Arthroplasty in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease